Skip to content
DataLookout
Menu

The First Affiliated Hospital with Nanjing Medical University clinical trial pipeline

Get alerts when The First Affiliated Hospital with Nanjing Medical University's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

10 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 9 with minor changes only.

  1. Notable: Goal-directed LCVP Based on HP in Laparoscopic Hepatectomy Enrollment increased: 100 → 160 participants The First Affiliated Hospital with Nanjing Medical UniversityNot applicable NCT05887661
  2. Minor: 6 trials marked Unknown by the registry's verification sweep Changed Registry verification sweep6 trials
    1. Minor: Ribociclib Combined With AI Versus Physician's Choice of Chemotherapy Sequential Endocrine Therapy in ER Middle-low-expression/HER2-negative Advanced Breast Cancer (Rachel) Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting The First Affiliated Hospital with Nanjing Medical UniversityPhase 2 NCT06656624
    2. Minor: Lactobacillus Vaginalis Capsules · Vulvovaginal Atrophy in Young Breast Cancer Patients Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting The First Affiliated Hospital with Nanjing Medical UniversityPhase 2 NCT05974449
    3. Minor: Thiotepa and Pomalidomide · Relapsed/Refractory Primary Central Nervous System Lymphoma Patients Changed Registry marked status Unknown (sponsor has not verified the record since Jun 2023); last known: Recruiting The First Affiliated Hospital with Nanjing Medical UniversityPhase 2 NCT05931328
    4. Minor: Multi-parametric Functional MRI in Patients of Chronic Kidney Disease Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Not Yet Recruiting The First Affiliated Hospital with Nanjing Medical UniversityNot specified NCT06639685
    5. Minor: High Resolution Diffusion Weighted Imaging in Prostate Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Recruiting The First Affiliated Hospital with Nanjing Medical UniversityNot specified NCT06636747
    6. Minor: Development of Tinnitus · SSNHL: Insights From fMRI and Metabolomics Changed Registry marked status Unknown (sponsor has not verified the record since Oct 2024); last known: Enrolling by Invitation The First Affiliated Hospital with Nanjing Medical UniversityNot specified NCT06355102
  3. Minor: Remimazolam for Reducing Postoperative Delirium in Elderly Patients Undergoing Laparoscopic Gastrectomy Sponsor refiled this as recruiting (was completed) The First Affiliated Hospital with Nanjing Medical UniversityNot applicable NCT07351474
  4. Minor: H-FROG · Perioperative Retlirafusp Alfa(Anti-PD-L1/TGF-β Bifunctional Fusion Protein) Plus Famitinib and GEMOX-Based Hepatic Arterial Infusion Chemotherapy for Locally Advanced Intrahepatic Cholangiocarcinoma: A Multicenter, Single-Arm, Exploratory Phase II Trial Interventions modified The First Affiliated Hospital with Nanjing Medical UniversityPhase 2 NCT07847710
  5. Minor: Durvalumab as Consolidation Therapy · LS-SCLC Following sCRT Trial completed The First Affiliated Hospital with Nanjing Medical UniversityNot specified NCT07309211
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-03 NCT07912606 D2 Gastrectomy With or Without Para-Aortic Lymph Node Dissection After Chemoimmunotherapy… Phase 2 Not Yet Recruiting
2026-10-30 NCT07906652 Clinical Evaluation of the Safety and Efficacy of "Buyan Huan Wu Tang" Combined With… Early Phase 1 Enrolling by Invitation
2026-10-29 NCT07902596 Lymph Node Dissection After Neoadjuvant Therapy for Gastric and EGJ Adenocarcinoma Not Yet Recruiting
2026-10-28 NCT07900516 A Prospective, Phase II, Exploratory Study Protocol of a Chemotherapy Sensitivity-based… Phase 2 Recruiting
2026-10-26 NCT07894640 Clinical Safety and Efficacy Evaluation of the Blood-cooling and Stasis-removing Formula… Early Phase 1 Enrolling by Invitation
2026-10-22 NCT07888621 Glofitamab Plus Gemcitabine and Oxaliplatin (GemOx) in Relapsed or Refractory Primary and… Phase 2 Not Yet Recruiting

Active trials by phase

Early Phase 1
13
Phase 1
8
Phase 1/2
5
Phase 2
85
Phase 3
13
Phase 4
9
Not charted: 120 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials, top 10 of 46

Get alerts when The First Affiliated Hospital with Nanjing Medical University's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free